CN109999164A - There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy - Google Patents

There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy Download PDF

Info

Publication number
CN109999164A
CN109999164A CN201910432394.0A CN201910432394A CN109999164A CN 109999164 A CN109999164 A CN 109999164A CN 201910432394 A CN201910432394 A CN 201910432394A CN 109999164 A CN109999164 A CN 109999164A
Authority
CN
China
Prior art keywords
parts
blood
radix
nourishing
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910432394.0A
Other languages
Chinese (zh)
Inventor
夏小军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910432394.0A priority Critical patent/CN109999164A/en
Publication of CN109999164A publication Critical patent/CN109999164A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/40Cornaceae (Dogwood family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486Millettia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638Ligustrum, e.g. Chinese privet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734Crataegus (hawthorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/808Scrophularia (figwort)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966Fritillaria, e.g. checker lily or mission bells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967Lilium, e.g. tiger lily or Easter lily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968Ophiopogon (Lilyturf)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of Chinese materia medica preparations with nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy, it is to carry out compatibility using American Ginseng, Radix Astragali, Radix Angelicae Sinensis, Radix Ophiopogonis, Schisandra chinensis, the fruit of glossy privet, eclipta, Fructus Corni, Caulis Spatholobi, raw lily, black nightshade, Rhizoma Chuanxiong, curcuma zedoary, radix scrophulariae, fritillaria thunbergii, raw oyster, semen coicis, hawthorn as bulk pharmaceutical chemicals, benefit attacks simultaneous apply, based on mending, it mends without high, the benefits of residing tonifying Qi, blood-nourishing, dissolving stasis, analgesic, invigorating the spleen, anticancer etc., amounting to nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors.Chinese materia medica preparation of the present invention has good therapeutic effect, total effective rate 98% to lung cancer.In addition, present invention composition is all using Chinese medicine as raw material, cooperation operation of lung cancer, chemotherapy, radiotherapy and reconvalescent is dialectical takes, nourishing qi and blood, righting is simultaneous with eliminating evil.

Description

There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy
Technical field
Invention belongs to technical field of traditional Chinese medicines, is related to a kind of Chinese medicine with nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors URIN Treatment lung cancer Preparation is mainly used for the Chinese medicine treatment in treatment phase and convalescence patients with lung cancer.
Background technique
" lung cancer " is a modern medicine noun, and " the lung in successive dynasties medical literature can be belonged to according to its clinical manifestation The diseases such as Kui ", " lung product ", " breath is beautifully adorned ", " membranous pharyngitis ", " hemoptysis ", " accumulation ", " pulmonary abscess ".Difficult Classic claims that " product of lung, name say breath It is beautifully adorned, it is multiple long endlessly, to make us spilling Zhejiang fever and chills, breath with cough as large as cup under right flank, send out lung Kui." in Southern Song Dynasty's " benevolence vegetarian directs at attached something lost side " Occur and lung cancer feature and its similar description.Jin and Yuan dynasty is emerged to cease beautifully adorned ball as a series for the treatment of coughs of representative, cough Blood, syndrome characterized by dyspnea, septum pectorale stop up the common disease recipe of lung cancer such as bored, vomiting sputum, face corpus luteum is thin.It is pointed out in " doctor's door benefit is wanted " clear Zhao Lian " ... though delay is not controlled eventually ", it is understood that though the therapy of lung cancer is more, prognosis is bad.
Though the formation of lung cancer, there are many factor, the Basic disease cause interpretation of the cause, onset and process of an illness is body negative and positive of qi and blood virtual loss.On this basis with The stagnation of the circulation of vital energy, blood stasis, phlegm knot, wet poly-, heat toxin etc. are mutually entangled with, with the passing of time stagnant to form tangible lump." six gas in the world, no year is not Have, when seven feelings of the person are not sent out, be it is ill have not patient what, lid qi and blood is prosperous and exopathogen cannot be felt, qi and blood decline and it is interior just not It can refuse, therefore the six external factors which cause diseases is hurt, and losing in qi and blood is hurt;Damaged by excess of seven emotions is hurt in the weary of qi and blood." its pathology attribute always belong to this void mark It is real, it consolidates headed by adjusting yang blood and qi balance, it is to want that temporary solution, which is worked as with dissipating phlegm and removing blood stasis removing toxic substances,.For advanced lung cancer pathogen being excessive but vital QI weak And the patient's treatment that healthy tendency declined of not dispelling of convalescence cult poison gives nourishing qi and blood, the Chinese materia medica preparation of strengthening vital QI to eliminate pathogenic factors meets lung cancer hair The rule of hair tonic exhibition.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine systems for lung cancer therapy with nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect Agent.
To achieve the above object, the technical scheme adopted by the invention is that: it is a kind of to be supported for lung cancer therapy with QI invigorating Blood, strengthening vital QI to eliminate pathogenic factors effect Chinese materia medica preparation, which is characterized in that be with American Ginseng, Radix Astragali, Radix Angelicae Sinensis, Radix Ophiopogonis, Schisandra chinensis, the fruit of glossy privet, Eclipta, Fructus Corni, Caulis Spatholobi, raw lily, black nightshade, Rhizoma Chuanxiong, curcuma zedoary, radix scrophulariae, fritillaria thunbergii, raw oyster, semen coicis, hawthorn are original Expect medicine, the oral preparations being prepared by the common process and auxiliary material of pharmacy.
American Ginseng, it is sweet, bitter, it trembles with fear.Return lung, stomach, the heart, kidney channel.Effect: supplementing qi and nourishing yin, clearing heat and promoting fluid.
Radix Astragali, sweet, warm.Return lung, the spleen channel.Effect: tonifying Qi and lifting yang, invigorating qi for consolidating superficies, and with nourishes blood and promotes the production of body fluid.
Radix Angelicae Sinensis, acrid, sweet, warm.Return liver, the heart, the spleen channel.Effect: replenishing and activating blood, menstruction regulating and pain relieving.
Caulis Spatholobi, sweet, bitter, temperature.Converge to heart and liver channels.Effect: promoting blood circulation, relaxing muscles and tendons.
Fructus Corni, sour, puckery, temperature.Return liver and kidney channel.Effect: it tonifies the liver and kidney, strengthening the essence is supporing yang, Heibei provincial opera yin-yang.
The fruit of glossy privet, sweet, bitter, cold.Return liver and kidney channel.
Eclipta, it is sweet, sour, it is cool.Return liver and kidney channel.Eclipta shares with the fruit of glossy privet, and name says two to nourishing liver and kidney.
American Ginseng, Radix Astragali, Radix Angelicae Sinensis, Caulis Spatholobi, Fructus Corni, the fruit of glossy privet and eclipta are monarch drug in a prescription altogether, play nourishing qi and blood altogether, mend The function of liver and kidney benefiting.
It is Radix Ophiopogonis, sweet, bitter, it trembles with fear.Return lung, stomach, the heart channel of Hang-Shaoyin.Effect: nourishing Yin and promoting production of body fluid, moistening lung and clearing away the heart-fire.
Schisandra chinensis, acid, sweet, warm.Return lung, the heart channel of Hang-Shaoyin.Effect: nourishing generate fluid, kidney calming.
Raw lily, it is sweet, it trembles with fear.Converge to heart and liver channels.Effect: Yin nourishing and lung moistening, clearing away the heart fire and tranquillizing.
Radix Ophiopogonis, Schisandra chinensis and raw lily are ministerial drug altogether, play the function of supplementing qi and nourishing yin, relieving restlessness tranquilizing the mind.
Rhizoma Chuanxiong, it is acrid in flavour and warm in nature.Return liver, gallbladder, pericardium channel.Effect: promote breath and open depression, promoting blood circulation and stopping pain.
Curcuma zedoary, pungent, bitter, temperature.Return liver, the spleen channel.Effect: promoting the circulation of qi, blood-breaking, disperse accumulation, analgesic.
Hawthorn, sweet, sour, temperature.Returns spleen, stomach, Liver Channel.Effect: scattered stasis.
Rhizoma Chuanxiong, curcuma zedoary and hawthorn are adjutant altogether, play the function of the promoting flow of qi and blood circulation, removing blood stasis and acesodyne.
Black nightshade, it is bitter, it trembles with fear.Effect: clearing heat and detoxicating, inducing diuresis for removing edema.
Semen coicis, it is sweet, light, it is cool.Return lung, spleen, kidney channel.Effect: invigorating the spleen excreting dampness, clearing away heat and eliminating pus.
Radix scrophulariae, it is sweet, bitter, salty, it trembles with fear.Return lung, stomach, kidney channel.Effect: clearing heat and cooling blood, nourishing yin and lessening fire, detoxicating and resolving a mass.
Fritillaria thunbergii, it is bitter, it trembles with fear.Return lung, the heart channel of Hang-Shaoyin.Effect: heat-clearing dissipating bind, preventing phlegm from forming and stopping coughing.
Raw oyster, it is salty, it trembles with fear.Return liver and kidney channel.Effect: resolving hard lump.
Black nightshade, semen coicis, radix scrophulariae, fritillaria thunbergii and raw oyster share altogether to make medicine, play the function of clearing heat and promoting diuresis, resolving hard lump.
Optimum ratio, by weight, by 15-20 parts of American Ginseng, 20-30 parts of Radix Astragali, 10-20 parts of Radix Angelicae Sinensis, Radix Ophiopogonis 5-15 part, 5-15 parts of Schisandra chinensis, 5-15 parts of the fruit of glossy privet, 5-15 parts of eclipta, 10-20 parts of Fructus Corni, 5-15 parts of Caulis Spatholobi, raw lily 10-20 Part, 5-15 parts of black nightshade, 5-15 parts of Rhizoma Chuanxiong, 5-15 parts of curcuma zedoary, 5-15 parts of radix scrophulariae, 10-20 parts of fritillaria thunbergii, 10-20 parts of raw oyster, the heart of a lotus seed 15-20 parts and hawthorn 10-20 parts compositions of the seed of jog's tears.
Optimum proportioning, 15 parts of American Ginseng, 20 parts of Radix Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, 10 parts of Schisandra chinensis, 10 parts of the fruit of glossy privet, 10 parts of eclipta, 15 parts of Fructus Corni, 15 parts of Caulis Spatholobi, 15 parts of raw lily, 10 parts of black nightshade, 10 parts of Rhizoma Chuanxiong, 10 parts of curcuma zedoary, radix scrophulariae 10 Part, 10 parts of fritillaria thunbergii, 15 parts of raw oyster, 15 parts of semen coicis, 10 parts of hawthorn.
Chinese materia medica preparation of the invention selects American Ginseng, Radix Astragali, Radix Angelicae Sinensis, Radix Ophiopogonis, Schisandra chinensis, the fruit of glossy privet, eclipta, mountain Zhu Cornel, Caulis Spatholobi, raw lily, black nightshade, Rhizoma Chuanxiong, curcuma zedoary, radix scrophulariae, fritillaria thunbergii, raw oyster, semen coicis, hawthorn are that bulk pharmaceutical chemicals are matched 5, by nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors, to have the function that eliminate lung cancer.The Chinese materia medica preparation benefit attack it is simultaneous apply, with mend based on, The benefits of mending without high, residence tonifying Qi, blood-nourishing, dissolving stasis, analgesic, invigorating the spleen, anticancer etc., amounting to nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors.
Modern research shows that American Ginseng, Radix Angelicae Sinensis, Radix Ophiopogonis, Schisandra chinensis, Fructus Corni, raw lily, the fruit of glossy privet and the heart of a lotus seed in the present invention The seed of jog's tears, which has, improves immune, antineoplastic action.Wherein American Ginseng can enhance the specificity of body by balanced immune reaction Immune response, to improve the immunity of body;It can also inhibit cancer cell multiplication simultaneously, play antineoplastic action.Radix Angelicae Sinensis water Extract has certain humidification to the specificity and non-specific immune function of body.Fructus Ligustri Lucidi polysaccharide is to Vitro Tumor The proliferation of cell is inhibited.When the methanolic extract of semen coicis acts on lung cancer A549 cell, lung cancer A549 is thin Born of the same parents are dead or stagnate proliferation.In addition Radix Astragali has good facilitation for humoral immunity and cellular immunity.Radix Angelicae Sinensis, Rhizoma Chuanxiong, Caulis Spatholobi, curcuma zedoary, radix scrophulariae, hawthorn etc. have the function of improvement hemodynamic, and wherein Radix Angelicae Sinensis can promote hematopoiesis, antithrombotic;Chicken Blood rattan general flavone reaches the mesh of anti-anemia action by promoting body secretes IL-3, the horizontal promotion erythroid hematopoiesis of adjusting EPO; Rhizoma Chuanxiong can significantly improve blood fluidity, inhibit platelet aggregation;Radix scrophulariae has antiplatelet aggregative activity;Hawthorn anti-oxidant can drop Blood lipid.Furthermore there are also anti-inflammatory, antivirus actions for the medicines such as the fruit of glossy privet, Schisandra chinensis, eclipta, curcuma zedoary, radix scrophulariae.Zeng Qiang is totally reached Immunity of organisms, antitumor, improvement hemodynamic and anti-inflammatory effect.
Chinese materia medica preparation of the invention can be prepared into oral preparations by the common process and auxiliary material of pharmacy, such as capsule, piece Agent, granule, pill, oral solution.
Here is that the present invention has nourishing qi and blood, the clinical statistics for lung cancer therapy Chinese materia medica preparation of strengthening vital QI to eliminate pathogenic factors effect Data.
1. observation object is quasi- to be included in standard compliant case 200, wherein women 110, male 90.Age is in 18- Between 80 years old.It is divided to two groups at random, control group: only receives the oncotherapy means of associated guideline recommendation, including operation, chemotherapy, put The treatment such as treatment.The use of Chinese medicine is provided as follows on the basis for the treatment of: (1) without using Chinese patent drug;(2) Chinese medicine injection is not used Agent;(3) decoction of medicinal ingredients is not used.Treatment group: increase Regimen with Traditional Chinese Medicine on the basis of the standard care that guide is recommended.Chinese traditional treatment side { syndrome is examined referring now to hospital's " primary lung cancer Chinese medicine diagnosis and treatment scheme " for specific method of syndrome differentiation, differentiation of symptoms and signs for classification of syndrome, treatment method in case It is disconnected: 1. syndrome of deficiency of both qi and yin: bringing up phlegm when one coughs or without phlegm, spiritlessness and weakness, sweating shortness of breath, dry fever, tidal fever in the afternoon, feverishness in palms and soles, Sometimes palpitaition, red tongue body tongue fur is thin or tongue nature is fat indentation, and arteries and veins is thin.2. asthenia of pulmonosplenic qi is demonstrate,proved: dilute phlegm of coughing long, shortness of breath uncomfortable in chest, mind are tired Power, abdominal distension and anorexia, edema loose stool, the light tongue fur of tongue nature is thin, while have indentation, deep thready pulse.3. syndrome of deficiency of lung yin: cough shortness of breath, dry cough phlegm is few, Hectic fever night sweat, dysphoria in chestpalms-soles, thirsty, hoarseness, red tongue with less fur or tongue body slight of stature, tongue fur are thin, thready rapid pulse.4. stagnation of the circulation of vital energy blood Stasis syndrome: cough shortness of breath and it is not well, shortness of breath is uncomfortable in chest, ambition shouting pain or distending pain, lump in the abdomen pain with tenderness, lip are dark, tongue is purple dark or has hemostasis Spot, tongue fur are thin, veins string or puckery.5. pulmonary retention of phlegmopyrexia is demonstrate,proved: abundant expectoration is coughed again, phlegm Huang is sticky, gas suppresses uncomfortable in chest, fever, indigestion and loss of appetite, red tongue body, tongue fur It is thick greasy or yellow, wiry and rolling pulse or and number.Diagnosis and treatment: 1. syndrome of deficiency of both qi and yin: therapy: supplementing qi and nourishing yin recommends recipe: the root of straight ladybell Mai Men Winter soup plus-minus.Raw Radix Astragali, the root of straight ladybell, the tuber of dwarf lilyturf, lily, radix scrophulariae, bulb of thunberg fritillary, almond, Sculellaria barbata, oldenlandia diffusa etc..Or have same The Chinese patent drug (including traditional Chinese medicine) of class effect.2. asthenia of pulmonosplenic qi is demonstrate,proved: therapy: recipe is recommended in strengthening the spleen and tonifying the lung, QI invigorating resolving sputum: Liujunzi Tang plus-minus.Raw Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Poria cocos, prepared RHIZOMA PINELLIZE without adju-vant, dried orange peel, campanulaceae, the raw seed of jog's tears, tendril-leaved fritillary bulb, almond etc..Or have The Chinese patent drug (including traditional Chinese medicine) of similar effect.3. syndrome of deficiency of lung yin: therapy: nourishing Yin and moistening lung, it is relieving cough and reducing sputum, recommend recipe: Maiwei-dihuang soup plus-minus.Radix Ophiopogonis, radix rehmanniae recen, cortex moutan, pulp of dogwood fruit, Schisandra chinensis, stir-baked RHIZOMA ANEMARRHENAE before sprinking salt solution, fritillaria thunbergii, full Snakegourd Fruit, Prunella vulgaris Deng.Or have effects that similar Chinese patent drug (including traditional Chinese medicine).4. syndrome of qi stagnation and blood stasis: therapy: the promoting flow of qi and blood circulation, stagnation resolvation solution Poison recommends recipe: Siwu Tang plus-minus.Radix angelicae sinensis, radix paeoniae rubra, hairyvein agrimony, the seed of jog's tears, Prunella vulgaris, corydalis tuber, fritillaria, curcuma zedoary etc..Or have The Chinese patent drug (including traditional Chinese medicine) of similar effect.5. pulmonary retention of phlegmopyrexia is demonstrate,proved: therapy: clearing heat and eliminating phlegm, the wet dissipating bind of Eradicates, recommendation side Medicine: erchen tang plus-minus.Dried orange peel, the tuber of pinellia, Poria cocos, Rhizoma Atractylodis Macrocephalae, Radix Codonopsis, the raw seed of jog's tears, almond, Snakegourd Fruit, radix scutellariae, reed stem, cymose buckwheat rhizome, fish raw meat Grass, Sculellaria barbata, oldenlandia diffusa etc..Or have effects that similar Chinese patent drug (including traditional Chinese medicine) } execute.Pass through control group Validity of the traditional Chinese medicine in lung cancer therapy is observed in research;It is evaluated in Synergy and attenuation, adverse reaction prevention and treatment, tumor recovering, section The about effect for the treatment of cost etc..
2. clinical symptoms have cough, expectoration, blood-stained sputum, the symptoms such as shortness of breath, uncomfortable in chest or pectoralgia, loss of appetite, waist and knee The symptoms such as aching and limp, spiritlessness and weakness.
3. treatment method, the paste medicine of Chinese materia medica preparation of the present invention, 50mL/ bags.Application method, each 1 bag sooner or later, January 1 Period, 3 period of overview.Period dietary, smoking ban, alcohol prohibition deactivate other products for oral administration, keep good hours, rule of life.
4. curative effect index
4.1 synergy indexs: treatment completion rate, solid tumor curative effect.
4.2 adverse reaction indexs: operation of lung cancer infectious-related complication, chemotherapy toxic side effect, early stage radioreaction.
4.3 tcm syndromes evaluation: referring to lung cancer tcm clinical practice sign in " new Chinese medicine clinical guidance principle " (2002 editions) Integral estimation.
4.5 Evaluation on quality of life: (FACT-L4.0 editions) evaluation therapeutic schemes pair of U.S.'s lung cancer Development of Quality of Life Scale are used The influence of life in patients.
5, treatment results
Short-term evaluation discovery is carried out after treating for 3 periods: it is 146 (accounting for 97.33%) that treatment completion rate, which compares treatment group, Control group is 120 (accounting for 80%), and two groups are compared P < 0.05;It is 135 (accounting for 90.00%) that solid tumor curative effect, which compares treatment group, right It is 115 (accounting for 76.7%) according to group, two groups are compared P < 0.05.
Adverse reaction metrics evaluation, operation of lung cancer infectious-related complication disease incidence aspect are comprehensively compared treatment group and (account for for 13 8.67%), control group is 24 (accounting for 16%), and two groups are compared P < 0.05;It is 135 that treatment group is comprehensively compared in terms of chemotherapy toxic side effect Example (accounting for 97.33%), control group are 147 (accounting for 98%), and two groups are compared P < 0.05;Compare treatment group in terms of early stage radiation side reaction For 115 (accounting for 76.7%), control group is 134 (accounting for 89.33%), and two groups are compared P < 0.05;Tcm syndrome evaluation is comprehensively compared Effective rates group is 140 (accounting for 93.33%), and control group is 89 (accounting for 59.33%);Life quality improvement rate overall merit ratio It is 123 (accounting for 82.00%) compared with treatment group, control group is 76 (accounting for 50.67%).
Above-mentioned clinical observation material shows that the drug of the present invention various clinical symptom common to lung cancer has treats well Effect.
It is purple imperial gold plaque that current existing treatment lung cancer Chinese patent drug and this preparation, which act on similar, wherein with Radix Astragali help spleen and lung Gas, shengjin nourishing;Radix Angelicae Sinensis, the Radix Curcumae promoting flow of qi and blood circulation, is tired of at cool blood at Radix Salviae Miltiorrhizae;Bittersweet, black nightshade, Sculellaria barbata, mock-strawberry powder for clearing heat and detoxicating Knot.Primary efficacy is nourishing qi and blood, clearing heat and detoxicating, qi-regulating stagnation resolvation, is suitable for primary lung cancer patients undergoing chemotherapy syndrome of deficiency of both qi and blood.It is suitable It is relatively narrow with range, and righting drug is few in side.Though the formation of lung cancer, there are many factor, the Basic disease cause interpretation of the cause, onset and process of an illness is body qi and blood yin Positive virtual loss.It is mutually entangled with the stagnation of the circulation of vital energy, blood stasis, phlegm knot, wet poly-, heat toxin etc. on this basis, it is with the passing of time stagnant to form tangible lump. Its pathology attribute always belongs to asthenia in origin and asthenia in superficiality, consolidates headed by adjusting yang blood and qi balance, it is to want that temporary solution, which is worked as with dissipating phlegm and removing blood stasis removing toxic substances,. American Ginseng, Radix Astragali, Radix Angelicae Sinensis, Caulis Spatholobi, Fructus Corni, the fruit of glossy privet and eclipta are monarch drug in a prescription altogether in the present invention, play nourishing qi and blood altogether, mend The function of liver and kidney benefiting.Radix Ophiopogonis, Schisandra chinensis and raw lily are ministerial drug altogether, play the function of supplementing qi and nourishing yin, relieving restlessness tranquilizing the mind.Rhizoma Chuanxiong, curcuma zedoary and mountain Short, bristly hair or beard is adjutant altogether, plays the function of the promoting flow of qi and blood circulation, removing blood stasis and acesodyne.It is to make that black nightshade, semen coicis, radix scrophulariae, fritillaria thunbergii and raw oyster share altogether Medicine plays the function of clearing heat and promoting diuresis, resolving hard lump.Complete square compatibility 5 is proper, applied widely based on righting, and with eliminating evil, for lung Cancer advanced stage pathogen being excessive but vital QI weak and convalescence the cult poison patient that healthy tendency has declined that do not dispel are applicable.
Specific embodiment
The raw material proportioning of drug of the present invention, preparation and usage and dosage side are made furtherly below by specific embodiment It is bright.
The preparation of embodiment 1, granules medicine
Composition of raw materials, by weight, 15 parts of American Ginseng, 20 parts of Radix Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, 10 parts of Schisandra chinensis, the fruit of glossy privet 10 parts, 10 parts of eclipta, 15 parts of Fructus Corni, 15 parts of Caulis Spatholobi, 15 parts of raw lily, 10 parts of black nightshade, 10 parts of Rhizoma Chuanxiong, 10 parts of curcuma zedoary, 10 parts of radix scrophulariae, 10 parts of fritillaria thunbergii, 15 parts of raw oyster, 15 parts of semen coicis, 10 parts of hawthorn.
Preparation process prepares the common process of granule by pharmacy and auxiliary material is prepared;Specification, 10g/ bags.
Usage and dosage, morning and evening each 20g, warm water is directly taken after mixing it with water, or is dissolved oral;The course for the treatment of, 1 period/January, overview 3 Period.
The preparation of embodiment 2, capsule medicine
Composition of raw materials, by weight, 15 parts of American Ginseng, 20 parts of Radix Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, 10 parts of Schisandra chinensis, the fruit of glossy privet 10 parts, 10 parts of eclipta, 15 parts of Fructus Corni, 15 parts of Caulis Spatholobi, 15 parts of raw lily, 10 parts of black nightshade, 10 parts of Rhizoma Chuanxiong, 10 parts of curcuma zedoary, 10 parts of radix scrophulariae, 10 parts of fritillaria thunbergii, 15 parts of raw oyster, 15 parts of semen coicis, 10 parts of hawthorn.
Preparation process prepares the common process of capsule by pharmacy and auxiliary material is prepared;Every 0.5g.
Application method, morning and evening each 2g, warm water is directly taken after mixing it with water, or is dissolved oral;The course for the treatment of, 1 period/January, overview 3 Period.
The preparation of embodiment 3, tablet medicine
Composition of raw materials, by weight, 15 parts of American Ginseng, 20 parts of Radix Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, 10 parts of Schisandra chinensis, the fruit of glossy privet 10 parts, 10 parts of eclipta, 15 parts of Fructus Corni, 15 parts of Caulis Spatholobi, 15 parts of raw lily, 10 parts of black nightshade, 10 parts of Rhizoma Chuanxiong, 10 parts of curcuma zedoary, 10 parts of radix scrophulariae, 10 parts of fritillaria thunbergii, 15 parts of raw oyster, 15 parts of semen coicis, 10 parts of hawthorn.
Preparation process prepares the common process of tablet by pharmacy and auxiliary material is prepared;Every 1.0g.
Application method, each 6 sooner or later, warm water is directly taken after mixing it with water, or is dissolved oral;The course for the treatment of, 1 period/January, overview 3 Period.
The preparation of embodiment 4, pill medicine
Composition of raw materials, by weight, 15 parts of American Ginseng, 20 parts of Radix Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, 10 parts of Schisandra chinensis, the fruit of glossy privet 10 parts, 10 parts of eclipta, 15 parts of Fructus Corni, 15 parts of Caulis Spatholobi, 15 parts of raw lily, 10 parts of black nightshade, 10 parts of Rhizoma Chuanxiong, 10 parts of curcuma zedoary, 10 parts of radix scrophulariae, 10 parts of fritillaria thunbergii, 15 parts of raw oyster, 15 parts of semen coicis, 10 parts of hawthorn.
Preparation process prepares the common process of pill by pharmacy and auxiliary material is prepared;Every ball 0.05g.
Application method, morning and evening each 9g, warm water is directly taken after mixing it with water, or is dissolved oral;The course for the treatment of, 1 period/January, overview 3 Period.
The preparation of embodiment 5, oral solutions
Composition of raw materials, 15 parts of American Ginseng, 20 parts of Radix Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, 10 parts of Schisandra chinensis, 10 parts of the fruit of glossy privet, ink drought 10 parts of lotus, 15 parts of Fructus Corni, 15 parts of Caulis Spatholobi, 15 parts of raw lily, 10 parts of black nightshade, 10 parts of Rhizoma Chuanxiong, 10 parts of curcuma zedoary, 10 parts of radix scrophulariae, 10 parts of fritillaria thunbergii, 15 parts of raw oyster, 15 parts of semen coicis, 10 parts of hawthorn.
Preparation process prepares the common process of oral solutions by pharmacy and auxiliary material is prepared;Every bag of 50mL.
Application method, morning and evening each 50mL, warm water is directly taken after mixing it with water, or is dissolved oral;The course for the treatment of, 1 period/January, overview 3 periods.
Embodiment 6
By weight, 17.5 parts of American Ginseng, 25 parts of Radix Astragali, 20 parts of Radix Angelicae Sinensis, 15 parts of Radix Ophiopogonis, 5 parts of Schisandra chinensis, 15 parts of the fruit of glossy privet, ink 15 parts of non-irrigated lotus, 20 parts of Fructus Corni, 5 parts of Caulis Spatholobi, 20 parts of raw lily, 15 parts of black nightshade, 15 parts of Rhizoma Chuanxiong, 15 parts of curcuma zedoary, 5 parts of radix scrophulariae, 20 parts of fritillaria thunbergii, 10 parts of raw oyster, 20 parts of semen coicis and 20 parts of hawthorn compositions.
The common process of pill is prepared by pharmacy and auxiliary material is prepared into pill;Every ball 0.05g.
Application method, morning and evening each 9g, warm water is directly taken after mixing it with water, or is dissolved oral;The course for the treatment of, 1 period/January, overview 3 Period.
Embodiment 7
By weight, 20 parts of American Ginseng, 30 parts of Radix Astragali, 10 parts of Radix Angelicae Sinensis, 5 parts of Radix Ophiopogonis, 15 parts of Schisandra chinensis, 5 parts of the fruit of glossy privet, eclipta 5 parts, 10 parts of Fructus Corni, 10 parts of Caulis Spatholobi, 10 parts of raw lily, 5 parts of black nightshade, 5 parts of Rhizoma Chuanxiong, 5 parts of curcuma zedoary, 15 parts of radix scrophulariae, fritillaria thunbergii 15 parts, 20 parts of raw oyster, 17.5 parts of semen coicis and 15 parts of hawthorn compositions.
The common process of tablet is prepared by pharmacy and auxiliary material is prepared into tablet;Every 1.0g.
Application method, each 6 sooner or later, warm water is directly taken after mixing it with water, or is dissolved oral;The course for the treatment of, 1 period/January, overview 3 Period.

Claims (4)

1. a kind of Chinese materia medica preparation for lung cancer therapy with nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect, which is characterized in that be with the West It is ginseng, Radix Astragali, Radix Angelicae Sinensis, Radix Ophiopogonis, Schisandra chinensis, the fruit of glossy privet, eclipta, Fructus Corni, Caulis Spatholobi, raw lily, black nightshade, Rhizoma Chuanxiong, curcuma zedoary, profound Ginseng, fritillaria thunbergii, raw oyster, semen coicis, hawthorn are bulk pharmaceutical chemicals, the interior system of mourning being prepared by the common process and auxiliary material of pharmacy Agent.
2. having the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy as described in claim 1, feature exists In each raw material medicaments in part by weight is matched, 15-20 parts of American Ginseng, 20-30 parts of Radix Astragali, 10-20 parts of Radix Angelicae Sinensis, Radix Ophiopogonis 5- 15 parts, 5-15 parts of Schisandra chinensis, 5-15 parts of the fruit of glossy privet, 5-15 parts of eclipta, 10-20 parts of Fructus Corni, 5-15 parts of Caulis Spatholobi, raw lily 10-20 parts, 5-15 parts of black nightshade, 5-15 parts of Rhizoma Chuanxiong, 5-15 parts of curcuma zedoary, 5-15 parts of radix scrophulariae, 10-20 parts of fritillaria thunbergii, raw oyster 10-20 Part, 15-20 parts of semen coicis, 10-20 parts of hawthorn.
3. having the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy as described in claim 1, feature exists In, each bulk pharmaceutical chemicals by being matched by weight, 15 parts of American Ginseng, 20 parts of Radix Astragali, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, the five tastes Sub 10 parts, 10 parts of the fruit of glossy privet, 10 parts of eclipta, 15 parts of Fructus Corni, 15 parts of Caulis Spatholobi, 15 parts of raw lily, 10 parts of black nightshade, Rhizoma Chuanxiong 10 Part, 10 parts of curcuma zedoary, 10 parts of radix scrophulariae, 10 parts of fritillaria thunbergii, 15 parts of raw oyster, 15 parts of semen coicis, 10 parts of hawthorn.
4. having the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors for lung cancer therapy as described in claim 1, which is characterized in that The oral preparations are capsule, tablet, granule, pill and oral solutions.
CN201910432394.0A 2019-05-23 2019-05-23 There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy Pending CN109999164A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910432394.0A CN109999164A (en) 2019-05-23 2019-05-23 There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910432394.0A CN109999164A (en) 2019-05-23 2019-05-23 There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy

Publications (1)

Publication Number Publication Date
CN109999164A true CN109999164A (en) 2019-07-12

Family

ID=67177689

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910432394.0A Pending CN109999164A (en) 2019-05-23 2019-05-23 There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy

Country Status (1)

Country Link
CN (1) CN109999164A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109985212A (en) * 2019-05-23 2019-07-09 夏小军 There is the Chinese materia medica preparation of mass dissipating and swelling eliminating, detoxification and removing stasis effect for lung cancer therapy
CN113640434A (en) * 2020-11-30 2021-11-12 天津中新药业集团股份有限公司隆顺榕制药厂 Construction method and application of high performance liquid chromatography fingerprint of Zilongjin tablets
CN114533837A (en) * 2022-02-18 2022-05-27 夏小军 Traditional Chinese medicine for strengthening body resistance and eliminating evil to treat lung cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101810767A (en) * 2010-03-11 2010-08-25 孟如 Chinese medicinal composition for tonifying qi and yin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101810767A (en) * 2010-03-11 2010-08-25 孟如 Chinese medicinal composition for tonifying qi and yin

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109985212A (en) * 2019-05-23 2019-07-09 夏小军 There is the Chinese materia medica preparation of mass dissipating and swelling eliminating, detoxification and removing stasis effect for lung cancer therapy
CN113640434A (en) * 2020-11-30 2021-11-12 天津中新药业集团股份有限公司隆顺榕制药厂 Construction method and application of high performance liquid chromatography fingerprint of Zilongjin tablets
CN114533837A (en) * 2022-02-18 2022-05-27 夏小军 Traditional Chinese medicine for strengthening body resistance and eliminating evil to treat lung cancer

Similar Documents

Publication Publication Date Title
CN101816770B (en) Chinese medicinal composition for treating diabetes and preparation method thereof
CN109985212A (en) There is the Chinese materia medica preparation of mass dissipating and swelling eliminating, detoxification and removing stasis effect for lung cancer therapy
CN109999164A (en) There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy
CN103585479A (en) Blood-replenishing pill and blood-replenishing capsule for treating iron-deficiency anemia
CN103263587B (en) Traditional Chinese medicine preparation for treating toxic and side effects of nasopharyngeal carcinoma after radiotherapy and preparation method thereof
CN102698100B (en) Oral solution for treating diabetes mellitus
CN102302567A (en) Stagnation-removing and stasis-removing Chinese patent medicine
CN101797342A (en) Traditional Chinese medicine for treating rheumatoid and chronic infectious arthritis
CN102784339A (en) Medicament for treating pulmonary tuberculosis by combined chemotherapy with traditional Chinese medicine Fuying and preparation method
CN105362904A (en) Qi tonifying and blood nourishing traditional Chinese medicinal pill and preparation method thereof
CN103272159B (en) Chinese herbal preparation used for treating consumptive disease and preparation method thereof
CN103893724A (en) Traditional Chinese medicine composition for treating liver depression and spleen deficiency type idiopathic edema of women
CN103705785A (en) Traditional Chinese medicine composition for treating advanced menstruation
CN102349979A (en) Oral traditional Chinese medicine composition for treating bitter taste in mouth
CN105833084A (en) Traditional Chinese medicine for treating oral ulcers
CN106581299B (en) Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof
CN105982906A (en) Application of 20(R)-ginsenoside Rg3 in preparing medicines or health products capable of alleviating or/and treating rheumatoid diseases and medicines
CN103920111A (en) Traditional Chinese medicament and capsule for treating lung infection type idiopathic edema and preparation method of traditional Chinese medicament and capsule
CN103041021A (en) Medicine for treatment of senile constipation
CN108542979A (en) A kind of natural herb flowers tea-drinking of speckle removing, acne removing beautifying face and moistering lotion
CN111759921B (en) Traditional Chinese medicine decoction for treating insomnia
CN101953994B (en) Chinese medicament for treating luekopenia after concurrent chemoradiotherapy
CN106729422A (en) A kind of raw arteries and veins pulvis curcumae Chinese medicine composition of adjuvant therapy radiotherapy and its application
CN105617260A (en) Preparation method of traditional Chinese medicine preparation for treating nasopharyngeal carcinoma
CN106606587A (en) Blood-tonifying body-tranquillizing pharmaceutical composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190712

RJ01 Rejection of invention patent application after publication